Gp120/CD4 Blocking Antibodies Are Frequently Elicited in ART-Naïve Chronically HIV-1 Infected Individuals-Reference-Cited by-同舟云学术

Gp120/CD4 Blocking Antibodies Are Frequently Elicited in ART-Naïve Chronically HIV-1 Infected Individuals

Published:2015-03-24 Issue:3 Volume:10 Page:e0120648
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Carrillo Jorge,Molinos-Albert Luis Manuel,de la Concepción Maria Luisa Rodríguez,Marfil Silvia,García Elisabet,Derking Ronald,Sanders Rogier W.,Clotet Bonaventura,Blanco Julià

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia;GD Tomaras;J Virol,2008

2. The role of antibodies in HIV vaccines;JR Mascola;Annu Rev Immunol,2010

3. Structural insights on the role of antibodies in HIV-1 vaccine and therapy;AP West;Cell,2014

4. Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning;PD Kwong;Nat Rev Immunol,2013

5. Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro;CF Barbas 3rd;Proc Natl Acad Sci U S A,1992

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope Glycoprotein;Viruses;2024-06-19

2. Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform—Analysis of Production and Immunogenicity;International Journal of Molecular Sciences;2023-05-19

3. HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic;Scientific Reports;2019-04-03

4. HIV-1 gp120 Upregulates Brain-Derived Neurotrophic Factor (BDNF) Expression in BV2 Cells via the Wnt/β-Catenin Signaling Pathway;Journal of Molecular Neuroscience;2017-05-30

5. First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses;Retrovirology;2016-11-28